Insights
infographic
Curia's Recently Filed DMFs
We offer a robust portfolio of market-leading APIs and world-class capabilities in niche and high-barrier-to-entry technologies.
article
The M.O. Behind Choosing a CDMO: Three Considerations for New Drug Developers
For many who are new to drug development, the greatest challenge is not necessarily discovering a blockbuster molecule—it’s finding a team capable of carrying that molecule through the complexities that lie between the research lab and the patien...
article
Rapid Drug Manufacturing Scale-Up: Best Practices
As pandemic conditions persist, the pharma industry continues to respond as rapidly as possible to bring more vaccine options to the global population. But developing one or more effective vaccines was just the first hurdle to clear. The drug industr...
webinar
Get the Most From Pharmaceutical X-ray Powder Diffraction Data Using Indexing
Watch this webinar to learn why indexing is a useful tool to glean additional information from X-ray powder diffraction data. The expert speaker will discuss the applications of indexing, including demonstrating pure crystalline phase identification...
publications patents
A Year In Review — Curia's Contributions to Science in 2020
The following research articles appeared in peer-reviewed scientific journals that described innovations conceived by Curia scientists. In most of these cases, these manuscripts were written by Curia lead authors to communicate independent research...
webinar
Casual Nexus – Episode Six: Biocatalysis, Biosynthesis and Fermentation - The Evolution of Chemistry via Biology
Presented by Pete Michels, Ph.D., Head of Global Fermentation, Curia Jose Luis Barredo, Ph.D., Director, Engineering Services, Curia Listen in as our experts discuss: A brief history of biocatalysis with a look at its current and futur...
webinar
Casual Nexus – Episode Five: Saving Time in Hit-to-Lead Investigations
Presented by Mark Wolf, Ph.D., Section Head, Medicinal Chemistry - Curia Doug Kitchen, Ph.D., Section Head, CADD, Medicinal Chemistry - Curia Listen in as our experts discuss: The importance of a strong hit-to-lead program in drug d...
webinar
Casual Nexus – Episode Four: Strategies for HPAPI Containment to Enable Rapid Development and Production
Presented by Brian Haney, Ph.D., Director of Technical Operations, Curia Iain MacGilp, Ph.D., Director, GMP Production, Curia Listen in as our experts discuss: The basics of handling HPAPI's safely in GMP production settings The trad...
white paper
The Shift Toward Western Pharmaceutical Manufacturing: Considerations in Attaining the Right Global Mix
The COVID-19 pandemic has brought the global interdependency of pharmaceutical supply chains into sharp focus, exposing weak links and re-igniting discussions around the value of reshoring production. The U.S. Food and Drug Administration (FDA) repor...
webinar
Casual Nexus – Episode Three: Sterile Drug Product Manufacturing During a Global Pandemic
Presenters: Ankit Agrawal, Senior Director, Commercial Strategy, Curia Anish Parikh, Vice President, Drug Product Sales & Marketing, Curia Listen in as our experts discuss: The shortage of sterile manufacturing capacity within CDMOs given...
webinar
Casual Nexus – Episode Two: T3P - A Versatile Peptide Coupling and Water Removal Reagent
Presenters: Peter Talbiersky, Ph.D., Manager of Fine Chemicals Sales, Curia Listen in as our experts discuss: The importance of a green and versatile condensation reagent Safe alternative for commonly used condensation reagents like dicyclohe...
webinar
Casual Nexus – Episode One: Formulation Development and Clinical Supply of Aseptic Liposomal
Presenters: Iain MacGilp, Ph.D., Director, GMP Production, Curia Amber McFarlane, Head of Formulation Development, Curia Listen in as our experts discuss: The importance of an integrated formulation development and clinical supply function th...